ArticleNPJ precision oncology2025

Genetic and epigenetic characterization of sarcoma stem cells across subtypes identifies EZH2 as a therapeutic target.

Edmond O'Donnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.